Scope
The work packages work towards the objectives and perform the activities leading to the products specified in the respective Special Agreements with ECDC as the project runs. The work package leaders are responsible for coordination of work within each work packages and for the timely delivery of products according to the Special Agreements with ECDC as part of the Framework Agreement.
Wor Package 1. Scientific Coordination and Project Management
The main objective of this work package is the overall scientific coordination and project management. It maximaizes scientific focus and productivity and promotes capacity building and transparent communication within and from the Consortium. It ensures that all actions are performed correctly and within the rules and regulations established in the Contracts and agreements and strives to achieve optimal synergy and cooperation.
| Name | Institution | Country |
| Jan Bonhoeffer | Brighton Collaboration | Switzerland |
| Daniel Weibel | Brighton Collaboration | Switzerland |
| Benus Becker | Brighton Collaboration | Switzerland |
| Norbert Sommerfeld | Brighton Collaboration | Switzerland |
| Sabine Faisst | Brighton Collaboration | Switzeralnd |
Work Package 2: Self Assesment Tool
The main objective of this work package is to engage in guidance of European Members States in evaluation of AEFI reporting systems based on a self assessment tool. This tool may serve as an instrument for assessing current surveillance systems as well as for guiding the establishment of new systems in European Member States
| Name | Institution | Country |
| Tuija Leino | National Institute of Health and Welfare | Finland |
| Giuseppe Tridente | Green Channel Reference Centre | Italy |
| Brigitte Keller-Stanislawski | Paul Ehrlich Institute | Germany |
| Hester de Melker | National Institute of Health | Netherlands |
| Harald Heijbel | Swedish Institute of Infectious Diseases | Sweden |
Work Package 3: Methods and Standards
The main objective of this work package is to engage in guidance of European Members States in establishing a methodological fremework, conducting proof of principle studies and evaluating opportunities and challenges of concerted collection, sharing, analysis and presentation of vaccine safety data derived from national and regional large linked data bases.
| Name | Institution | Country |
| Brigitte Keller Stanislawski | Paul Ehrlich Institute | Germany |
| Anders Hviid | Statens Serum Institut | Denmark |
| Jukka Jokinen | National Institute of Health and Welfare | Finland |
| Silvana Romio | Erasmus Medical Center Rotterdam | Netherlands |
| Miriam Sturkenboom | Erasmus Medical Center Rotterdam | Netherlands |
| Jeanne Dielemann | Erasmus Medical Center Rotterdam | Netherlands |
| Piotr Kramarz | European Centre of Disease Prevention and Control | Sweden |
| Kari Johansen | European Centre of Disease Prevention and Control | Sweden |
| Jan Bonhoeffer | Brighton Collaboration | Switzerland |
| Daniel Weibel | Brighton Collaboration | Switzerland |
| Nick Andrews | Health Protection Agency | United Kingdom |
Work Package 4: European Vaccine Safety Data Link
The main objective of this work package is to engage European Member States in conducting epidemiologic studies relavent to the safety of vaccines based on linking large health care databases. The emphasis is to establish the necessary infrastructure and to conduct vaccine safety studies benefitting from European collaboration and of high public health importance to Member States.
| Name | Institution | Country |
| Miriam Sturkenboom | Erasmus medical center | Netherlands |
| Anders Hviid | Stantens Serum Institut | Denmark |
| Ditte Mölgaard-Nielsen | Stantens Serum Institut | Denmark |
| Henrik Svanström | Stantens Serum Institut | Denmark |
| Hanna Nohynek | National Institute of Health and Welfare | Finland |
| Jukka Jokinen | National Institute of Health and Welfare | Finland |
| Terhi Kilpi | National Institute of Health and Welfare | Finland |
| Anne Castot | French Medicines Agency (AFSSAPS) | France |
| Christel Saussier | French Medicines Agency (AFSSAPS) | France |
| Yves Dauvilliers | University Hospital Montpellier | France |
| Dirk Menzer | Paul Ehrlich Institute | Germany |
| Geert Mayer | Hephata Clinic | Germany |
| Keller Stanislawski Brigitte | Paul Ehrlich Institute | Germany |
| Carmela Santuccio | Italian Medicines Agency( AIFA) | Italy |
| Franceso Trotta | Italian Medicines Agency( AIFA) | Italy |
| Ann Vanrolleghem | Erasmus Medical Center | Netherlands |
| Jeanne Dieleman | Erasmus Medical Center | Netherlands |
| Martijn Schuemie | Erasmus medical center | Netherlands |
| Mees Mosseveld | Erasmus medical center | Netherlands |
| Silvana Romio | Erasmus Medical Center | Netherlands |
| Hester de Melker | National Institute of Health | Netherlands |
| Nicoline van der Maas | National Institute of Health | Netherlands |
| Jann Storsaeter | Norwegian Institute of Health | Norway |
| Harald Heijbel | Swedish Institute of Infectious Diseases | Sweden |
| Kari Johansen | European Centre of Disease Prevention and Control | Sweden |
| Piotr Kramarz | European Centre of Disease Prevention and Control | Sweden |
| Lisen Arnheim Dahlström | Karolinska Institute | Sweden |
| Par Sparen | Karolinska Institute | Sweden |
| Jan Bonhoeffer | Brighton Collaboration | Switzerland |
| Daniel Weibel | Brighton Collaboration | Switzerland |
| Corinne de Vries | University of Bath | United Kingdom |
| Cormac Sammon | University of Bath | United Kingdom |
| Nick Andrews | Health Protection Agency | United Kingdom |
